Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 11Recruiting 9Active not recruiting 5Unknown 2Terminated 2Not yet recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroblastoma 2

Interventions

Temozolomide 66Radiotherapy 52Carboplatin 25Bevacizumab 21Cisplatin 19Radiosurgery 18Vincristine 17Etoposide 17Cyclophosphamide 17Surgical Procedures, Operative 13Magnetic Resonance Spectroscopy 13Chemotherapy, Adjuvant 11Melphalan 10Lomustine 10Drug Therapy 10Filgrastim 9Erlotinib Hydrochloride 9apatinib 8Pemetrexed 83-Iodobenzylguanidine 8anlotinib 7Radiation 7Peripheral Blood Stem Cell Transplantation 7Methotrexate 7Thiotepa 6Isotretinoin 6Irinotecan 6Ifosfamide 6Doxorubicin 6Carmustine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × dinutuximab × CNS × Clear all
NCT02743429 2021-10-04

Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma

University Medicine Greifswald

Phase 2 Unknown
40 enrolled
CNS

Neuroblastoma

NCT00030719 2014-06-24

Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Unknown
175 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡